Cocrystal Pharma, Inc. 8-K

What Happened
Cocrystal Pharma, Inc. filed a Form 8-K on March 13, 2026 (Item 5.02) announcing that the company learned on March 10, 2026 that Dr. Anthony Japour, a member of its board of directors, passed away.

Key Details

• Filing: Form 8-K filed March 13, 2026, reported under Item 5.02 (Departure of Directors or Certain Officers).
• Date of notification: The company learned of Dr. Japour’s death on March 10, 2026.
• The filing notifies investors of the director’s passing; it does not announce a replacement or other board appointments.

Why It Matters
This filing informs shareholders that the board has lost a director. Investors should monitor future SEC filings and company announcements for any updates on board composition, committee assignments, or governance changes resulting from this vacancy.